STOCK TITAN
  1. Home
  2. Financials
  3. GMRBV

GMRBV Financials

GMRBV
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows GMRBV (GMRBV) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GMRBV FY2025

A depreciation-heavy, asset-intensive model keeps producing cash even as reported earnings slipped into a -$6.9M loss.

Across the last three fiscal years, operating cash flow stayed near $70M even as net income moved from profit to loss, which points to earnings being heavily shaped by non-cash charges rather than a collapse in day-to-day cash generation. That fits a cost structure where about $58.0M of annual depreciation and $31.8M of interest absorb much of what the assets produce before it reaches net income.

The business looks capital intensive: it carries roughly $1.24B of assets to support only $148.2M of annual revenue, so a large operating base is required to generate a relatively small sales stream. That structure helps explain why return on assets fell to just -0.6% when earnings turned negative.

Cash on hand was only $9.1M against $712.4M of liabilities, so this is not a company sitting behind a large liquidity buffer; it appears to depend more on the steadiness of operating inflows than on idle cash. Continued shareholder payouts and buybacks totaling about $11.8M in the loss year also suggest management treated the reported loss as weaker accounting income, not a breakdown in cash generation.

Generated by Rhea from SEC filings [ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 25 / 100
Financial Profile 25/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of GMRBV's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
38

GMRBV's revenue grew 6.8% year-over-year to $148.2M, a solid pace of expansion. This earns a growth score of 38/100.

Leverage
100

GMRBV carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Returns
12

GMRBV generates a -1.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 12/100. This is down from 1.3% the prior year.

Piotroski F-Score Neutral
5/9

GMRBV passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
-10.69x

For every $1 of reported earnings, GMRBV generates $-10.69 in operating cash flow ($73.6M OCF vs -$6.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$148.2M
YoY+6.8%
5Y CAGR+9.6%
10Y CAGR+53.3%

GMRBV generated $148.2M in revenue in fiscal year 2025. This represents an increase of 6.8% from the prior year.

EBITDA
N/A
Net Income
-$6.9M
YoY-202.9%

GMRBV reported -$6.9M in net income in fiscal year 2025. This represents a decrease of 202.9% from the prior year.

EPS (Diluted)
$-0.91
YoY-1616.7%

GMRBV earned $-0.91 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1616.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$9.1M
YoY+33.3%
5Y CAGR+10.5%
10Y CAGR-0.1%

GMRBV held $9.1M in cash against $1.2M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
13M
YoY-1.0%

GMRBV had 13M shares outstanding in fiscal year 2025. This represents a decrease of 1.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
-4.6%
YoY-9.5pp
5Y CAGR-2.0pp
10Y CAGR+73.4pp

GMRBV's net profit margin was -4.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 9.5 percentage points from the prior year.

Return on Equity
-1.4%
YoY-2.6pp
5Y CAGR-0.8pp

GMRBV's ROE was -1.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.6 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$6.0M

GMRBV spent $6.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
N/A

GMRBV Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $38.1M-0.9% $38.4M+3.1% $37.2M-1.9% $38.0M+9.7% $34.6M-1.5% $35.2M+2.6% $34.3M+0.1% $34.2M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $5.1M-7.4% $5.5M+13.0% $4.9M-19.3% $6.0M+66.4% $3.6M-53.0% $7.7M+75.9% $4.4M-4.5% $4.6M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $7.2M-13.9% $8.4M+2.8% $8.2M+2.1% $8.0M+11.7% $7.2M-5.3% $7.6M+4.6% $7.2M+3.5% $7.0M
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income $1.7M+126.9% -$6.1M-21.5% -$5.1M-964.6% $585K-84.3% $3.7M+27.2% $2.9M-13.3% $3.4M+273.7% -$2.0M
EPS (Diluted) $-0.06 N/A $-0.45 $-0.01-106.3% $0.16 N/A $0.14+380.0% $-0.05

GMRBV Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $1.2B-0.4% $1.2B-2.4% $1.3B-1.8% $1.3B+2.2% $1.3B+1.0% $1.3B+1.1% $1.2B+0.1% $1.2B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $8.2M-9.9% $9.1M+27.5% $7.1M+8.3% $6.6M+21.6% $5.4M-20.6% $6.8M+19.1% $5.7M+15.0% $5.0M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $6.8M-5.9% $7.2M-9.1% $7.9M+1.5% $7.8M-3.4% $8.1M+9.2% $7.4M-8.6% $8.1M+0.6% $8.1M
Goodwill $5.9M0.0% $5.9M0.0% $5.9M0.0% $5.9M0.0% $5.9M0.0% $5.9M0.0% $5.9M0.0% $5.9M
Total Liabilities $717.4M+0.7% $712.4M-7.2% $767.4M-0.6% $771.9M+5.5% $731.5M+4.4% $700.6M+3.3% $678.0M+2.3% $662.8M
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A $1.2M0.0% $1.2M-91.9% $14.2M-0.7% $14.3M-1.1% $14.4M-0.7% $14.5M-1.0% $14.7M
Total Equity $500.2M-1.9% $509.8M+5.0% $485.3M-3.6% $503.2M-2.7% $517.4M-3.1% $534.1M-1.6% $542.6M-2.5% $556.4M
Retained Earnings -$360.6M-3.1% -$350.0M-5.2% -$332.6M-5.1% -$316.5M-3.5% -$305.7M-4.1% -$293.7M-4.5% -$281.1M-4.5% -$268.9M

GMRBV Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $13.4M-38.3% $21.6M+23.2% $17.6M-20.7% $22.1M+80.4% $12.3M-40.2% $20.5M+25.9% $16.3M-13.9% $18.9M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$9.8M-245.9% $6.7M+1059.9% -$703K+98.2% -$39.2M-44.1% -$27.2M-39.4% -$19.5M+23.4% -$25.5M-1527.9% $1.8M
Financing Cash Flow -$4.4M+83.1% -$26.3M-62.1% -$16.2M-186.8% $18.7M+37.7% $13.6M+8787.6% $153K-98.3% $9.2M+144.2% -$20.7M
Dividends Paid $10.9M+651.3% $1.5M+0.1% $1.5M-0.1% $1.5M+0.1% $1.5M-0.1% $1.5M+0.1% $1.5M-0.1% $1.5M
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

GMRBV Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 4.3%+20.4pp -16.0%-2.4pp -13.6%-15.1pp 1.5%-9.3pp 10.8%+2.4pp 8.4%-1.5pp 9.9%+15.6pp -5.7%
Return on Equity 0.3%+1.5pp -1.2%-0.2pp -1.0%-1.2pp 0.1%-0.6pp 0.7%+0.2pp 0.5%-0.1pp 0.6%+1.0pp -0.4%
Return on Assets 0.1%+0.6pp -0.5%-0.1pp -0.4%-0.5pp 0.1%-0.2pp 0.3%+0.1pp 0.2%-0.0pp 0.3%+0.4pp -0.2%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 1.43+1.4 0.000.0 0.00-0.0 0.030.0 0.030.0 0.030.0 0.030.0 0.03
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Frequently Asked Questions

GMRBV (GMRBV) reported $148.2M in total revenue for fiscal year 2025. This represents a 6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

GMRBV (GMRBV) revenue grew by 6.8% year-over-year, from $138.8M to $148.2M in fiscal year 2025.

No, GMRBV (GMRBV) reported a net income of -$6.9M in fiscal year 2025, with a net profit margin of -4.6%.

GMRBV (GMRBV) reported diluted earnings per share of $-0.91 for fiscal year 2025. This represents a -1616.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, GMRBV (GMRBV) had $9.1M in cash and equivalents against $1.2M in long-term debt.

GMRBV (GMRBV) had a net profit margin of -4.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

GMRBV (GMRBV) has a return on equity of -1.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

GMRBV (GMRBV) generated $73.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

GMRBV (GMRBV) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, GMRBV (GMRBV) spent $6.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

GMRBV (GMRBV) had 13M shares outstanding as of fiscal year 2025.

GMRBV (GMRBV) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

GMRBV (GMRBV) had a return on assets of -0.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

GMRBV (GMRBV) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

GMRBV (GMRBV) has an earnings quality ratio of -10.69x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

GMRBV (GMRBV) scores 25 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top